Codex DNA Inc
NASDAQ:DNAY
Income Statement
Earnings Waterfall
Codex DNA Inc
Revenue
|
27.4m
USD
|
Cost of Revenue
|
-11.8m
USD
|
Gross Profit
|
15.6m
USD
|
Operating Expenses
|
-62.1m
USD
|
Operating Income
|
-46.5m
USD
|
Other Expenses
|
-2m
USD
|
Net Income
|
-48.5m
USD
|
Income Statement
Codex DNA Inc
Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|
Revenue | ||||
Revenue |
7
N/A
|
11
+68%
|
27
+148%
|
|
Gross Profit | ||||
Cost of Revenue |
(3)
|
(7)
|
(12)
|
|
Gross Profit |
4
N/A
|
4
+19%
|
16
+263%
|
|
Operating Income | ||||
Operating Expenses |
(20)
|
(40)
|
(62)
|
|
Selling, General & Administrative |
(11)
|
(25)
|
(39)
|
|
Research & Development |
(9)
|
(15)
|
(23)
|
|
Operating Income |
(16)
N/A
|
(35)
-116%
|
(46)
-31%
|
|
Pre-Tax Income | ||||
Interest Income Expense |
(2)
|
(3)
|
(1)
|
|
Non-Reccuring Items |
0
|
(1)
|
(1)
|
|
Total Other Income |
(0)
|
(0)
|
(0)
|
|
Pre-Tax Income |
(18)
N/A
|
(39)
-116%
|
(48)
-24%
|
|
Net Income | ||||
Tax Provision |
(0)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(18)
|
(39)
|
(48)
|
|
Net Income (Common) |
(18)
N/A
|
(39)
-116%
|
(48)
-24%
|
|
EPS (Diluted) |
-0.62
N/A
|
-2.14
-245%
|
-1.65
+23%
|